NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer
Translational Oncology(2023)
Abstract
•NLRC5 potentiates antitumor responses of CD8+ T cells against EC.•IFN-β promotes immunosurveillance of EC by activating CD8+ T cells.•NLRC5 potentiates antitumor responses of CD8+ T cells to EC by activating IFN-β.
MoreTranslated text
Key words
Endometrial cancer, NLR family CARD domain-containing 5,Interferon-β,CD8+ T cells,Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined